CliffBio
small molecule

CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF

CETIRIZINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyTris. →See this company's full patent-cliff portfolio

Drug detail

Brand nameCHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
Active ingredientCETIRIZINE HYDROCHLORIDE
Strength5MG/5ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2012
Marketing statusDISCN

More from Tris.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF patent cliff — loss of exclusivity — | CliffBio